PATENT CLAIM ANALYSIS

Application Number: 16194430
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "04400A"]

Abstract:
A method of treating a lipid-related disorder in a subject in need thereof is disclosed. The method comprises administering to the subject a therapeutically effective amount of a polynucleotide agent which is substantially complementary to a nucleotide sequence of human miR-132, thereby treating the lipid related disorder in the subject.

Claim (Index 19):
The method of  claim 15 , wherein said polynucleotide comprises a modified nucleic acid unit selected from the group consisting of locked nucleic acid unit, 2\u2032-O-alkyl ribonucleic acid unit, 2\u2032amine ribonucleic acid unit, peptide nucleic acid unit, 2\u2032fluoro-ribo nucleic acid unit, morpholino nucleic acid unit, cyclohexane nucleic acid unit and a tricyclonucleic acid unit.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 98.0
- Lexical Diversity: 1.51429
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15511648', '14701150', '15293728', '13979428', '14342867']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8172619528365871
- 35 USC 102 Novelty (BERT): 0.6345381383969053
- Combined Prediction Score: 0.798989571392619
- Mean Citation Score: 390.252188
- Max Citation Score: 652.5515
- Similarity Product: 541.8386582793892

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test